MedPath

GUAIFENESIN

Drug Facts

Approved
Approval ID

3867a132-1a87-5e08-e063-6294a90a6dc8

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Aug 1, 2025

Manufacturers
FDA

Sam's West Inc

DUNS: 051957769

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

GUAIFENESIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68196-960
Application NumberANDA210453
Product Classification
M
Marketing Category
C73584
G
Generic Name
GUAIFENESIN
Product Specifications
Route of AdministrationORAL
Effective DateAugust 1, 2025
FDA Product Classification

INGREDIENTS (10)

GUAIFENESINActive
Quantity: 1200 mg in 1 1
Code: 495W7451VQ
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYPROMELLOSE 2208 (15000 MPA.S)Inactive
Code: Z78RG6M2N2
Classification: IACT
HYPROMELLOSE 2910 (10000 MPA.S)Inactive
Code: 0HO1H52958
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSE 101Inactive
Code: 7T9FYH5QMK
Classification: IACT
MICROCRYSTALLINE CELLULOSE 102Inactive
Code: PNR0YF693Y
Classification: IACT
POVIDONE K90Inactive
Code: RDH86HJV5Z
Classification: IACT
POVIDONE K25Inactive
Code: K0KQV10C35
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 8/1/2025

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg Blister Carton (56 (4 x 14)

Tablets)

Member's
Mark™****

COMPARE TO** MAXIMUM STRENGTH**
MUCINEX®***ACTIVE INGREDIENT

NDC 68196-960-56

MAXIMUM STRENGTH

Mucus Relief
****GUAIFENESIN EXTENDED-RELEASE TABLETS, 1200 mg
********GUAIFENESIN 1200 mg-EXPECTORANT

Relieves chest congestion

Actual Size

56
Extended-Release
Tablets

*Relieves chest congestion *Thins and loosens mucus

12
HR

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg Blister Carton (56 (4 x 14) Tablets)

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 8/1/2025

Uses

  • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

WARNINGS SECTION

LOINC: 34071-1Updated: 8/1/2025

Warnings

Do not use

OTC - DO NOT USE SECTION

LOINC: 50570-1Updated: 8/1/2025
  • for children under 12 years of age

OTC - ASK DOCTOR SECTION

LOINC: 50569-3Updated: 8/1/2025

Ask a doctor before use if you have

  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • cough accompanied by too much phlegm (mucus)

OTC - STOP USE SECTION

LOINC: 50566-9Updated: 8/1/2025

Stop use and ask a doctor if

  • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

OTC - PREGNANCY OR BREAST FEEDING SECTION

LOINC: 53414-9Updated: 8/1/2025

**If pregnant or breast-feeding,**ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 8/1/2025

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 8/1/2025

Active ingredient

(in each extended-release tablet)

Guaifenesin USP 1200 mg

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 8/1/2025

Purpose

Expectorant

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 8/1/2025

Directions

  • do not crush, chew, or break extended-release tablet
  • take with a full glass of water
  • this product can be administered without regard for timing of meals
  • adults and children 12 years of age and over: 1 extended-release tablet every 12 hours. Do not exceed 2 extended-release tablets in 24 hours.
  • children under 12 years of age: do not use

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 8/1/2025

Other information

  • store between 20° to 25°C (68° to 77°F)

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 8/1/2025

Inactive ingredients

colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, and pregelatinised starch (maize)

Questions?

1-855-274-4122(Monday – Friday 8:30 AM to 5:00 PM EST)

DISTRIBUTED BY:
SAM'S WEST, INC.
BENTONVILLE AR 72716

Made in India

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GUAIFENESIN - FDA Drug Approval Details